Cisplatin/Hydrogel complex in cancer therapy

Biomacromolecules

Volumn 10, Issue 4, 2009, Pages 944-949

  Casolaro, Mario ^a   Cini, Renzo ^a   Bello, Barbara Del ^a   Ferrali, Marco ^a   Maellaro, Emilia ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RESIDUES; CANCER THERAPIES; CARBOXYLATE GROUPS; CISPLATIN; CISPLATINUM; CONTROLLED PROCESS; CYTOTOXIC ACTIVITIES; CYTOTOXIC EFFECTS; L HISTIDINES; L PHENYLALANINES; MELANOMA CELLS; MOLAR RATIOS; MONOMERIC UNITS; N-ISOPROPYLACRYLAMIDE; PHOSPHATE BUFFER SOLUTIONS; PLATINUM SPECIES; SOLUBLE POLYMERS; THERAPEUTIC AGENTS;

ACRYLIC MONOMERS; AMIDES; AMINES; AMINO ACIDS; CARBOXYLATION; CELL CULTURE; DIMETHYL SULFOXIDE; ORGANIC ACIDS; PLATINUM; PLATINUM COMPOUNDS; STOICHIOMETRY;

HYDROGELS;

ACRYLAMIDE DERIVATIVE; CISPLATIN; DIMETHYL SULFOXIDE; HISTIDINE DERIVATIVE; PHENYLALANINE DERIVATIVE; PHOSPHATE; WATER; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER; HISTIDINE; HYDROGEL; N-ISOPROPYLACRYLAMIDE; PHENYLALANINE; POLYMER;

CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG EFFECT; DRUG RELEASE; HUMAN; HUMAN CELL; HYDROGEL; MELANOMA CELL; PRIORITY JOURNAL; STOICHIOMETRY; VISCOMETRY; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; MELANOMA; METABOLISM; PATHOLOGY; SECONDARY; SKIN NEOPLASMS; TUMOR CELL CULTURE;

ACRYLAMIDES; ANTINEOPLASTIC AGENTS; CISPLATIN; DELAYED-ACTION PREPARATIONS; DIMETHYL SULFOXIDE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HISTIDINE; HUMANS; HYDROGELS; MELANOMA; PHENYLALANINE; POLYMERS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; WATER;

EID: 65249110970     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm8014939     Document Type: Conference Paper

References (32)

1. DeConti, R. C.; Toftness, B. R.; Lange, R. C.; Creasey, W. A. Cancer Res. 1973, 33, 1310-1315.
2. Reedijk, J.; Teuben, J. M. In Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; Lippert, B., Ed.; Wiley-VCH: Zurich, Switzerland, 1999; p 339.
3. Kelland, L.; Farrel, N. Platinum Based Drug in Cancer Therapy. Humana Press: Totowa, NJ, 2000.
4. Garattini, S.; La Vecchia, C. Eur. J. Cancer 2001, 37, 128-147.
5. Lebwohl, D.; Canetta, R. Eur. J. Cancer 1998, 34, 1522-1534.
6. Ferguson, L. R.; Pearson, A. E. Mutat. Res. 1996, 355, 1-12.
7. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. J. Controlled Release 2000, 65, 271-284.
8. Sasaki, H.; Niimi, S.; Akiyama, M.; Tanaka, T.; Hazato, A.; Kurozumi, S.; Fukusima, S.; Fusushima, S. Cancer Res. 1999, 59, 3919-3922.
9. Araki, H.; Tani, T.; Kodama, M. Artif. Organs 1999, 23, 161-168.
10. Itoi, K.; Tabata, Y.; Ike, O.; Shimizu, Y.; Kuwabara, M.; Kyo, M.; Hyon, S. H.; Ikada, Y. J. Controlled Release 1996, 42, 175-184.
11. Tokuda, K.; Natsugoe, S.; Shimada, M.; Kumanohoso, T.; Baba, M.; Takao, S.; Nakamura, K.; Yamada, K.; Yosizawa, H.; Hatate, Y.; Aikou, T. Int. J. Cancer 1998, 76, 709-712.
12. Mizumura, Y.; Matsumura, Y.; Hamaguchi, T.; Nishiyama, N.; Kataoka, K.; Kawaguchi, T.; Hrushesky, W. J.; Moriyasu, F.; Kakizoe, T. Jpn. J. Cancer Res. 2001, 92, 328-336.
13. Burger, K. N. J.; Staffhorst, R. W. H. M.; De Vijlder, H. C.; Velinova, M. J.; Bomans, P. H.; Frederik, P. M.; De Kruijff, B. Nat. Med. 2002, 8, 81-84.
14. Yan, X.; Gemeinhart, R. A. J. Controlled Release 2005, 106, 198 208.
15. Kopecek, J.; Kopeckova, P.; Minko, T.; Lu, Z.-R.; Peterson, C. M. J Controlled Release 2001, 74, 147-158.
16. Komane, L. L.; Mukaya, E. H.; Neuse, E. W.; van Rensburg, C. E. J. J. Inorg. Organomet. Polym. 2008, 18, 111-123.
17. Yapp, D. T. T.; Lloyd, D. K.; Zhu, J.; Lehnert, S. M. AntiCancer Drugs 1998, 9, 791-796.
18. Cini, R.; Defazio, S.; Tamasi, G.; Casolaro, M.; Messori, L.; Casini, A.; Morpurgo, M.; Hursthouse, M. Inorg. Chem. 2007, 46, 79-92.
19. Tamasi, G.; Serinelli, F.; Consumi, M.; Magnani, A.; Casolaro, M.; Cini, R. J. Inorg. Biochem. 2008, 102, 1862-1873.
20. Uhrich, K. E.; Cannizzaro, S. M.; Langer, R. S.; Shakesheff, K. M. Chem. Rev. 1999, 99, 3181-3198.
21. Casolaro, M.; Paccagnini, E.; Mendichi, R.; Ito, Y. Macromolecules 2005, 38, 2460-2468.
22. Casolaro, M.; Ito, Y.; Ishii, T.; Bottari, S.; Samperi, F.; Mendichi, R. eXPRESS Polym. Lett. 2008, 2, 165-183.
23. Casolaro, M.; Bottari, S.; Ito, Y. Biomacromolecules 2006, 7, 1439 1448.
24. Golla, E. D.; Ayres, G. H. Talanta 1973, 20, 199-210.
25. Del Bello, B.; Valentini, M. A.; Mangiavacchi, P.; Comporti, M.; Maellaro, E. Exp. Cell Res. 2004, 293, 302-310.
26. Del Bello, B.; Moretti, D.; Gamberucci, A.; Maellaro, E. Oncogene 2007, 26, 2717-2726.
27. Brockhaus, F.; Brune, B. Exp. Cell. Res. 1998, 238, 33-41.
28. Cisplatin: Chemistry and Biochemistry ofa Leading Anticancer Drug; Lippert, B., Ed.; Wiley-VCH: Zurich, Switzerland, 1999.
29. Sundquist, W. I.; Ahmed, K. J.; Hollis, L. S.; Lippard, S. I. Inorg. Chem. 1987, 26, 1524-1528.
30. Fisher, S. J.; Benson, L. M.; Fauq, A.; Naylor, S.; Windebank, A. J. NeuroToxicology 2008, 29, 444-452.
31. Peppas, A. N.; Korsmeyer, R. W. In Hydrogels in Medicine and Pharmacy; Peppas, N. A., Ed.; CRC Press: Boca Raton, FL, 1987; p 109.
32. Sileni, V. C.; Fosser, V.; Maggian, P.; Padula, E.; Beltrame, M.; Nicolini, M.; Arslan, P. Cancer Chemother. Pharmacol. 1992, 30, 221-225.